Marketing-authorisation holder · Spain
Hipra Human Health S.L.
6 medicines in 2 countries, as authorisation holder and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Spain
6 medicines in 2 countries, as authorisation holder and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Bimervax | Covid-19 vaccine | EU (EMA) | Authorised | 2023 |
| BIMERVAX EMULSION INYECTABLE40 µg · Emulsion inyectable | Vacuna proteina recombinante heterodimeros del dominio union al receptor del virus sars-cov-2 adyuvada | Spain | Authorised | 2023 |
| BIMERVAX LP.8.1 EMULSION INYECTABLE40 µg/dosis · Emulsion inyectable | Meracovateina | Spain | Marketed | 2025 |
| BIMERVAX LP.8.1 EMULSION INYECTABLE EN JERINGA PRECARGADA40 µg/dosis · Emulsion inyectable | Meracovateina | Spain | Authorised | 2026 |
| BIMERVAX XFG.1.1 EMULSION INYECTABLE40 µg/dosis · Emulsion inyectable | Vacuna proteina recombinante homodimeros fusion del dominio union al receptor la proteina la espicula del virus sars-cov-2 adyuvada | Spain | Marketed | 2026 |
| BIMERVAX XFG.1.1 EMULSION INYECTABLE EN JERINGA PRECARGADA40 µg/dosis · Emulsion inyectable y para perfusion en jeringa precargada | Vacuna proteina recombinante homodimeros fusion del dominio union al receptor la proteina la espicula del virus sars-cov-2 adyuvada | Spain | Marketed | 2026 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 5 | 5 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.